Bioterrorism Defense Bill Could Change Patent Law
In its bid to protect the U.S. from biological terrorism, Capitol Hill is sparking a battle between the pharmaceutical industry and its generics rivals over new patent and market exclusivity in...To view the full article, register now.
Already a subscriber? Click here to view full article